<DOC>
	<DOC>NCT02188290</DOC>
	<brief_summary>Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).</brief_summary>
	<brief_title>Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia, Myeloid, Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia, Lymphoid</mesh_term>
	<criteria>Any of the following hematologic malignancies: Acute myeloid leukemia (AML) in remission at the time of the transplantation Acute lymphoblastic leukemia (ALL) in remission at the time of the transplantation Myelodysplastic syndrome (MDS) Patient received any of the following transplantations: Allogeneic Tcell depleted HSCT without ATIR administration from a haploidentical donor between 1 January 2006 and 30 June 2013 (HAPLO group) Allogeneic HSCT from a fully matched or 1locus mismatched unrelated donor between 1 January 2010 and 31 December 2012 (MUD/MMUD groups) Double umbilical cord blood transplantation between 1 January 2010 and 31 December 2012 with no more than 2 human leukocyte antigen (HLA)mismatches at HLAA, B, and/or DR between each of the units and the recipient (UCB group) Male or female, age ≥ 18, ≤ 65 years. Allogeneic stem cell transplantation prior to the transplantation qualifying for the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Haploidentical donor</keyword>
	<keyword>Unrelated donor</keyword>
	<keyword>Umbilical cord blood</keyword>
	<keyword>Graft versus host disease</keyword>
	<keyword>Transplant-related mortality</keyword>
	<keyword>Hematologic malignancy</keyword>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
</DOC>